Home  /  Resource Library  /  Sequential PD-1 inhibitors as consolidative therapy post-CD19 CART in relapsed/refractory NHL: a propensity score matching cohort study

Sequential PD-1 inhibitors as consolidative therapy post-CD19 CART in relapsed/refractory NHL: a propensity score matching cohort study

Study examined PD-1 inhibitors following CAR-T therapy for treatment of relapsed lymphomas.